Farmalyse is a contract service provider for the pharmaceutical industry, hospitals and the medical device industry offering a full range of laboratory investigation services, quality control testing, analytical method development-validation and comprehensive and customised international services which focus on import, release and supply chain management.
Farmalyse is accredited with relevant good manufacturing practice (GMP), control laboratory practice (GcLP), ISO 9002 and ISO 14385 certifications. Our services are also calibrated to the OECD-GLP and ICH guidelines.
With over 12 years of experience in the industry, we serve our clients with a strong emphasis on reliability and speed. Offering flexibility to customers' requirements on reliable throughput times and maintaining a strong emphasis on quality assurance, we provide a customised tailor-made package of services sensitive to the requirements and specifications of our sponsors.
Our experience and expertise, together with that of our global clients and our partner network, assure the best of reliability, speed and quality in all Farmalyse services.
Quality control testing and laboratory investigations
One of the core competencies of Farmalyse is to provide specific solutions for clients to apply to their business model and outsourcing needs. With over 90% retention of sponsors, we take pride in offering them the best of our services and continually grow with them to adapt to their requirements and needs.
Farmalyse provides services in four broad domains:
- Quality control testing (raw materials to finished products)
- Laboratory investigations
- Qualified person (QP), regulatory (RA) and quality assurance (QA) services
- International services
Laboratory contract services
We cater to more than 100 clients from across the world, including the UK, mainland Europe, the Middle East, India and the US in a variety of industry sectors and sub-sectors, such as generics, medical devices, proprietary products, raw materials, hospitals and cosmetics.
Our major clients include Novartis, Astellas, Ranbaxy Laboratories, Actavis, Abbott, and Schering-Plough among others.
Pieter Lieftinckweg 2